RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 134 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,178 | -33.9% | 214,053 | -21.0% | 0.00% | – |
| Q2 2023 | $349,645 | -49.3% | 271,043 | -48.1% | 0.00% | – |
| Q1 2023 | $690,000 | +267341.9% | 522,507 | +204.3% | 0.00% | – |
| Q4 2022 | $258 | -99.8% | 171,708 | +33.1% | 0.00% | – |
| Q3 2022 | $152,000 | +42.1% | 129,015 | +36.5% | 0.00% | – |
| Q2 2022 | $107,000 | -62.3% | 94,529 | -0.6% | 0.00% | – |
| Q1 2022 | $284,000 | +41.3% | 95,074 | +25.6% | 0.00% | – |
| Q4 2021 | $201,000 | -27.2% | 75,698 | -0.7% | 0.00% | – |
| Q3 2021 | $276,000 | -14.6% | 76,223 | +2.5% | 0.00% | – |
| Q2 2021 | $323,000 | +47.5% | 74,377 | +16.1% | 0.00% | – |
| Q1 2021 | $219,000 | -89.2% | 64,068 | -89.0% | 0.00% | – |
| Q4 2020 | $2,033,000 | +1302.1% | 580,990 | +817.2% | 0.00% | – |
| Q3 2020 | $145,000 | -80.4% | 63,345 | -84.3% | 0.00% | – |
| Q2 2020 | $740,000 | -25.3% | 404,139 | -36.3% | 0.00% | – |
| Q1 2020 | $990,000 | +149.4% | 634,392 | +241.8% | 0.00% | – |
| Q4 2019 | $397,000 | +285.4% | 185,626 | +236.6% | 0.00% | – |
| Q3 2019 | $103,000 | -92.9% | 55,149 | -90.7% | 0.00% | – |
| Q2 2019 | $1,449,000 | +1280.0% | 591,364 | +1343.7% | 0.00% | – |
| Q1 2019 | $105,000 | +6.1% | 40,961 | -4.5% | 0.00% | – |
| Q4 2018 | $99,000 | -77.2% | 42,885 | -68.3% | 0.00% | – |
| Q3 2018 | $435,000 | -89.1% | 135,432 | -90.4% | 0.00% | -100.0% |
| Q2 2018 | $3,986,000 | -44.3% | 1,408,433 | -30.3% | 0.00% | -50.0% |
| Q1 2018 | $7,157,000 | +34.8% | 2,021,618 | +47.7% | 0.00% | +100.0% |
| Q4 2017 | $5,311,000 | +63.7% | 1,368,762 | -2.1% | 0.00% | 0.0% |
| Q3 2017 | $3,245,000 | -18.7% | 1,398,650 | -4.3% | 0.00% | 0.0% |
| Q2 2017 | $3,990,000 | -16.9% | 1,461,550 | +0.8% | 0.00% | 0.0% |
| Q1 2017 | $4,799,000 | +13.1% | 1,449,714 | -18.7% | 0.00% | 0.0% |
| Q4 2016 | $4,245,000 | -46.5% | 1,783,488 | -17.5% | 0.00% | -50.0% |
| Q3 2016 | $7,936,000 | +124.0% | 2,162,247 | +36.1% | 0.00% | +100.0% |
| Q2 2016 | $3,543,000 | +11329.0% | 1,588,725 | +14311.5% | 0.00% | – |
| Q4 2013 | $31,000 | -90.5% | 11,024 | -87.9% | 0.00% | – |
| Q3 2013 | $327,000 | +53.5% | 91,252 | +43.2% | 0.00% | – |
| Q2 2013 | $213,000 | – | 63,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |